Followers | 185 |
Posts | 10548 |
Boards Moderated | 0 |
Alias Born | 11/23/2007 |
Saturday, March 18, 2017 2:35:34 PM
http://www.esperion.com/targeting-unmet-needs/
Recent ESPR News
- Esperion Announces a Featured Presentation in the Late Breaker/Featured Science Track and Three Poster Presentations Accepted for the 2024 American Heart Association (AHA) Scientific Sessions • GlobeNewswire Inc. • 10/31/2024 12:00:00 PM
- Esperion to Report Third Quarter 2024 Financial Results on November 7 • GlobeNewswire Inc. • 10/24/2024 12:00:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 10/22/2024 10:06:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2024 08:08:47 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/17/2024 07:25:29 PM
- Esperion EU Partner Reports Final Real-World Results from MILOS German Cohort Demonstrating Strong Increase in LDL-C Goal Achievement With Addition of Bempedoic Acid • GlobeNewswire Inc. • 10/02/2024 12:00:00 PM
- Esperion Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/25/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 08:12:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 08:11:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/17/2024 08:02:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/17/2024 07:28:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/17/2024 07:20:06 PM
- Esperion to Participate in Upcoming 2024 Cantor Global Healthcare Conference • GlobeNewswire Inc. • 09/05/2024 12:00:00 PM
- Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) • GlobeNewswire Inc. • 09/03/2024 12:00:00 PM
- Esperion to Participate in Upcoming H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 08/26/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:03:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/19/2024 07:50:08 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/12/2024 08:33:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:08:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 11:21:11 AM
- Esperion Reports Second Quarter 2024 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 08/12/2024 10:00:00 AM
- U.S. Futures Steady as Markets Await Key Inflation Data, Oil Prices Climb • IH Market News • 08/12/2024 09:47:41 AM
- Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/07/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 08:34:24 PM
- Esperion to Report Second Quarter 2024 Financial Results on August 12 • GlobeNewswire Inc. • 07/25/2024 12:00:00 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM